188 related articles for article (PubMed ID: 34668818)
21. Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2.
Eleraky NE; El-Badry M; Omar MM; El-Koussi WM; Mohamed NG; Abdel-Lateef MA; Hassan AS
Int J Nanomedicine; 2023; 18():5831-5869. PubMed ID: 37869062
[TBL] [Abstract][Full Text] [Related]
22. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
23. Contributions of
Ukai Y; Kuroiwa M; Kurihara N; Naruse H; Homma T; Maki H; Naito A
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126960
[No Abstract] [Full Text] [Related]
24. Olive oil and clove oil-based nanoemulsion for topical delivery of terbinafine hydrochloride:
Gul U; Khan MI; Madni A; Sohail MF; Rehman M; Rasul A; Peltonen L
Drug Deliv; 2022 Dec; 29(1):600-612. PubMed ID: 35174738
[TBL] [Abstract][Full Text] [Related]
25. Development and Optimization of Hyaluronic Acid-Poloxamer In-Situ Gel Loaded with Voriconazole Cubosomes for Enhancement of Activity against Ocular Fungal Infection.
Alhakamy NA; Hosny KM; Rizg WY; Eshmawi BA; Badr MY; Safhi AY; Murshid SSA
Gels; 2022 Apr; 8(4):. PubMed ID: 35448142
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis.
Tavakoli N; Taymouri S; Saeidi A; Akbari V
Pharm Dev Technol; 2019 Sep; 24(7):891-901. PubMed ID: 31062987
[TBL] [Abstract][Full Text] [Related]
27. Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis.
Hosny KM; Sindi AM; Ali S; Alharbi WS; Hajjaj MS; Bukhary HA; Badr MY; Mushtaq RY; Murshid SSA; Almehmady AM; Bakhaidar RB; Alfayez E; Kurakula M
Drug Deliv; 2022 Dec; 29(1):254-262. PubMed ID: 35014929
[No Abstract] [Full Text] [Related]
28. Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses.
Cuming RS; Abarca EM; Duran S; Wooldridge AA; Stewart AJ; Ravis W; Babu RJ; Lin YJ; Hathcock T
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2746-2754. PubMed ID: 28549089
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy.
Peng HS; Liu XJ; Lv GX; Sun B; Kong QF; Zhai DX; Wang Q; Zhao W; Wang GY; Wang DD; Li HL; Jin LH; Kostulas N
Int J Pharm; 2008 Mar; 352(1-2):29-35. PubMed ID: 18053659
[TBL] [Abstract][Full Text] [Related]
31. Novel ethosomal gel of clove oil for the treatment of cutaneous candidiasis.
Shetty S; Jose J; Kumar L; Charyulu RN
J Cosmet Dermatol; 2019 Jun; 18(3):862-869. PubMed ID: 30171656
[TBL] [Abstract][Full Text] [Related]
32. Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia.
Wang X; Zhao J; Wen T; Liao X; Luo B
Pharmacology; 2021; 106(3-4):202-210. PubMed ID: 32998136
[TBL] [Abstract][Full Text] [Related]
33. Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole.
Qin T; Dai Z; Xu X; Zhang Z; You X; Sun H; Liu M; Zhu H
Curr Pharm Biotechnol; 2021; 22(2):245-253. PubMed ID: 32867650
[TBL] [Abstract][Full Text] [Related]
34. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
35. Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery.
Andrade LM; Rocha KA; De Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
Cornea; 2016 Jun; 35(6):866-71. PubMed ID: 27055213
[TBL] [Abstract][Full Text] [Related]
36. Inflammation is a potential risk factor of voriconazole overdose in hematological patients.
Gautier-Veyret E; Truffot A; Bailly S; Fonrose X; Thiebaut-Bertrand A; Tonini J; Cahn JY; Stanke-Labesque F
Fundam Clin Pharmacol; 2019 Apr; 33(2):232-238. PubMed ID: 30306637
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice.
Paul P; Sengupta S; Mukherjee B; Shaw TK; Gaonkar RH; Debnath MC
Nanomedicine (Lond); 2018 Mar; 13(5):501-520. PubMed ID: 29383985
[TBL] [Abstract][Full Text] [Related]
38. Innovation of natural essential oil-loaded Orabase for local treatment of oral candidiasis.
Labib GS; Aldawsari H
Drug Des Devel Ther; 2015; 9():3349-59. PubMed ID: 26170621
[TBL] [Abstract][Full Text] [Related]
39. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
Pawar P; Kashyap H; Malhotra S; Sindhu R
Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
[TBL] [Abstract][Full Text] [Related]
40. Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.
Sharma C; Kumar R; Kumar N; Masih A; Gupta D; Chowdhary A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
